Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE.
Eur J Endocrinol. 2019 Jul;181(1):45-53. doi: 10.1530/EJE-18-0901.
Eur J Endocrinol. 2019.
PMID: 31067510